M
Mesoblast
Biotech & Life Sciences · Melbourne, Australia · Founded 2004 · IPO 2004 Unicorn
Investors
1 investor on Mesoblast's cap table
Sourced from Dealroom's funding history. Investor profile links are shown where available.
Global footprint
Where Mesoblast has talent and traffic
team presence
across markets
Patent intelligence
$242M patent portfolio · 86 active families
Where Mesoblast concentrates vs peers
Each axis is a top-10 topic across Mesoblast and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Market sentiment
What the market is saying about Mesoblast
An AI-synthesized read of the highest-engagement posts about Mesoblast on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Mesoblast on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.